C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) C07K 14/415 (2006.01) C07K 14/50 (2006.01) C07K 19/00 (2006.01) C12N 1/21 (2006.01) C12N 9/00 (2006.01) C12N 15/13 (2006.01) C12N 15/16 (2006.01) C12N 15/29 (2006.01) C12N 15/52 (2006.01) C12N 15/70 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2138038
2138038 9325688 PCTABScor01 Methods for the recombinant production of saporin-containing proteins, including cell surface binding protein-saporin fusion proteins, are provided. The resulting fusion proteins are cytotoxic to targeted cells. In preferred embodiments, methods are provided for the production of basic fibroblast factor (bFGF)-saporin fusion proteins by culturing Escherichia coli that has been transformed with a vector containing DNA encoding bFGF linked via a spacer peptide to the amino terminus of a cytotoxic portion of a saporin polypeptide to obtain expression of the DNA, and isolating the resulting FGF-saporin fusion protein. FGF-saporing fusion proteins and saporin proteins containing from about 5 to 12 amino acid N-terminal extensions are also provided.
Baird J. Andrew
Barthelemy Isabel
Lappi Douglas A.
Sosnowski Barbara A.
Oyen Wiggs Green & Mutala Llp
Prizm Pharmaceuticals Inc.
Whittier Institute For Diabetes And Endocrinology
LandOfFree
Recombinant production of saporin-containing proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant production of saporin-containing proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant production of saporin-containing proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1689473